Hallek M - Search Results

1

CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.

Wendtner CM, Schmitt B, Gruss HJ, Druker BJ, Emmerich B, Goodwin RG, Hallek M. Wendtner CM, et al. Among authors: hallek m. Cancer Res. 1995 Sep 15;55(18):4157-61. Cancer Res. 1995. PMID: 7545087

2

Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.

Danhauser-Riedl S, Warmuth M, Druker BJ, Emmerich B, Hallek M. Danhauser-Riedl S, et al. Among authors: hallek m. Cancer Res. 1996 Aug 1;56(15):3589-96. Cancer Res. 1996. PMID: 8758931

3

Signal transduction of interleukin-6 involves tyrosine phosphorylation of multiple cytosolic proteins and activation of Src-family kinases Fyn, Hck, and Lyn in multiple myeloma cell lines.

Hallek M, Neumann C, Schäffer M, Danhauser-Riedl S, von Bubnoff N, de Vos G, Druker BJ, Yasukawa K, Griffin JD, Emmerich B. Hallek M, et al. Exp Hematol. 1997 Dec;25(13):1367-77. Exp Hematol. 1997. PMID: 9406996

4

Chronotherapy with 5-fluorouracil and folinic acid in advanced colorectal carcinoma. Results of a chronopharmacologic phase I trial.

Adler S, Lang S, Langenmayer I, Eibl-Eibesfeldt B, Rump W, Emmerich B, Hallek M. Adler S, et al. Among authors: hallek m. Cancer. 1994 Jun 15;73(12):2905-12. doi: 10.1002/1097-0142(19940615)73:12<2905::aid-cncr2820731206>3.0.co;2-j. Cancer. 1994. PMID: 8199987 Clinical Trial.

5

Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.

Neumann C, Zehentmaier G, Danhauser-Riedl S, Emmerich B, Hallek M. Neumann C, et al. Among authors: hallek m. Eur J Immunol. 1996 Feb;26(2):379-84. doi: 10.1002/eji.1830260217. Eur J Immunol. 1996. PMID: 8617307

6

Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells.

Hallek M, Danhauser-Riedl S, Herbst R, Warmuth M, Winkler A, Kolb HJ, Druker B, Griffin JD, Emmerich B, Ullrich A. Hallek M, et al. Br J Haematol. 1996 Jul;94(1):5-16. doi: 10.1046/j.1365-2141.1996.6102053.x. Br J Haematol. 1996. PMID: 8757502

7

Gene transfer of the costimulatory molecules B7-1 and B7-2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response.

Wendtner CM, Nolte A, Mangold E, Buhmann R, Maass G, Chiorini JA, Winnacker EL, Emmerich B, Kotin RM, Hallek M. Wendtner CM, et al. Among authors: hallek m. Gene Ther. 1997 Jul;4(7):726-35. doi: 10.1038/sj.gt.3300447. Gene Ther. 1997. PMID: 9282174

8

The activation of intracellular tyrosine kinases by interferon-alpha (IFNalpha) correlates with its antiproliferative activity in B-lymphoid cell lines, but not in B-cell chronic lymphocytic leukemia patients.

von Bubnoff N, Adler S, Danhauser-Riedl S, Kamp T, Nerl C, Emmerich B, Hallek M. von Bubnoff N, et al. Among authors: hallek m. Ann Hematol. 2000 Mar;79(3):119-26. doi: 10.1007/s002770050566. Ann Hematol. 2000. PMID: 10803933

9

Reduced responsiveness of adenylate cyclase to forskolin in human lymphoma cells.

Hallek M, Kamp T, Haen E, Göhly U, Emmerich B, Remien J. Hallek M, et al. Biochem Pharmacol. 1991 Sep 12;42(7):1329-34. doi: 10.1016/0006-2952(91)90442-8. Biochem Pharmacol. 1991. PMID: 1656984 Free article.

10

Defects of beta 2-adrenergic signal transduction in chronic lymphocytic leukaemia: relationship to disease progression.

Kamp T, Liebl B, Haen E, Emmerich B, Hallek M. Kamp T, et al. Among authors: hallek m. Eur J Clin Invest. 1997 Feb;27(2):121-7. doi: 10.1046/j.1365-2362.1997.700623.x. Eur J Clin Invest. 1997. PMID: 9061305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

827 results

Search Page

Filters